Automatic Segmentation Ultrasound-based Radiomics Technology in Diabetic Kidney Disease
NCT ID: NCT05025540
Last Updated: 2022-02-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
499 participants
OBSERVATIONAL
2021-06-01
2021-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Application of Ultrasound Integrated Precision Diagnosis Technology in Prevention of Kidney Disease and Its Progress
NCT04044404
Prognostic Imaging Biomarkers for Diabetic Kidney Disease
NCT03716401
Establish and Apply the Evaluation System of Ultrasonic Integrated Technology for Prevention and Treatment of Acute Kidney Injury
NCT02347930
Contrast-enhanced Ultrasound and Super-resolution Imaging Predict Renal Function Outcome After Nephrectomy
NCT07294859
Development of Early Diagnostic Techniques and Setup of Local Therapeutic Guidelines and Standards
NCT00912704
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study aims to explore the detection of diabetic kidney disease and its pathological degree based on automatic segmentation ultraound-based radiomics technology, mining of internal information of ultrasound images, and form a set of non-invasive monitoring of diabetic kidney disease complications development system, especially in primary medical institutions, has a broad clinical application prospect.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group
Experimental group1:DKD patients with Type 2 diabetes patients with DKD Experimental group2:High level DKD patients with diabetic kidney disease Stage III and IV.
ultrasonic imaging
Two-dimensional ultrasound images of the patient's kidneys were obtained by ultrasound imaging.
Control group
Control1:T2DM patients with Type 2 diabetes Control2:Low level DKD patients with diabetic kidney disease Stage I and II.
ultrasonic imaging
Two-dimensional ultrasound images of the patient's kidneys were obtained by ultrasound imaging.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ultrasonic imaging
Two-dimensional ultrasound images of the patient's kidneys were obtained by ultrasound imaging.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients with clear B mode ultrasound imaging in both side of kidney (left and right).
* No missing value in the vital clinical data such as eGFR and UACR.
Exclusion Criteria
* Ultrasound images with severe shadow or incomplete kidney border were excluded.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pintong Huang
Role: STUDY_CHAIR
Department of Ultrasound, The Second Affiliated Hospital of Zhejiang University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The People's Hospital of Yingshang
Fuyang, Anhui, China
Tianjin Third Central Hospital
Tianjin, Tianjin Municipality, China
Department of Ultrasound, Second Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-0465
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.